LifeCell is India’s largest & most accredited stem cell bank and the first to bring the revolutionary concept of umbilical cord stem cell banking to India in 2004 in technological collaboration with Cryo-Cell International USA -the world’s first private stem cell bank. LifeCell is headquartered at Chennai with an advanced laboratory & research facility in adherence to strict International guidelines. The stringent standards followed by LifeCell have received many International accreditations from AABB (American Association of Blood Banks), CAP (College of American Pathologists), and NABL (National Accreditation Board for Calibration and Testing Laboratories). LifeCell is the first company in India to receive prestigious AABB accreditation for cord blood banking, and importantly it is also the second in the world to be accredited for cord tissue banking services.

Since inception LifeCell has grown at a consistent pace and has strongly established its leadership position in the industry, with its coverage extending to over 100 cities and towns in India. As leaders LifeCell had the responsibility of educating the public and medical fraternity on stem cell technology and through these efforts today over 65,000 parents have preserved their baby’s cord blood stem cells with LifeCell. Considering LifeCell’s leadership position and growth, the company was honoured as one amongst ‘India’s Most Promising Brand’ for 2011-2012 by 4Ps Business and Marketing. The company is also championing several initiatives in the stem cell therapy area through partnerships and in-house R&D efforts. LifeCell is the sole distributor for USFDA approved point-of-care medical device that can provide a patient’s stem cells from the bone marrow within 15 minutes from by the bed-side, which is useful for applications in orthopaedic, vascular and cardiovascular specialities. With these significant achievements and leadership, LifeCell has uniquely positioned itself as a comprehensive stem cells solutions provider with a complete spectrum of services in stem cells through multi-service stem cell banking, R&D, clinical trials and stem cell therapy.